Yi KH - Search Results

1

PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system.

Beaver JA, Gustin JP, Yi KH, Rajpurohit A, Thomas M, Gilbert SF, Rosen DM, Ho Park B, Lauring J. Beaver JA, et al. Among authors: yi kh. Clin Cancer Res. 2013 Oct 1;19(19):5413-22. doi: 10.1158/1078-0432.CCR-13-0884. Epub 2013 Jul 25. Clin Cancer Res. 2013. PMID: 23888070 Free PMC article.

2

Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine.

Yi KH, Axtmayer J, Gustin JP, Rajpurohit A, Lauring J. Yi KH, et al. Oncotarget. 2013 Jan;4(1):29-34. doi: 10.18632/oncotarget.755. Oncotarget. 2013. PMID: 23237847 Free PMC article.

3

Engineering targeted chromosomal amplifications in human breast epithelial cells.

Springer S, Yi KH, Park J, Rajpurohit A, Price AJ, Lauring J. Springer S, et al. Among authors: yi kh. Breast Cancer Res Treat. 2015 Jul;152(2):313-21. doi: 10.1007/s10549-015-3468-2. Epub 2015 Jun 23. Breast Cancer Res Treat. 2015. PMID: 26099605 Free PMC article.

4

Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity.

Yi KH, Lauring J. Yi KH, et al. Oncotarget. 2016 Jan 26;7(4):4241-51. doi: 10.18632/oncotarget.6648. Oncotarget. 2016. PMID: 26701849 Free PMC article.

5

Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.

Yi KH, Nechushtan H, Bowers WJ, Walker GR, Zhang Y, Pham DG, Podack ER, Federoff HJ, Tolba KA, Rosenblatt JD. Yi KH, et al. Cancer Res. 2007 Oct 15;67(20):10027-37. doi: 10.1158/0008-5472.CAN-06-2391. Cancer Res. 2007. PMID: 17942937

6

Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells.

Shah S, Divekar AA, Hilchey SP, Cho HM, Newman CL, Shin SU, Nechustan H, Challita-Eid PM, Segal BM, Yi KH, Rosenblatt JD. Shah S, et al. Among authors: yi kh. Int J Cancer. 2005 Nov 20;117(4):574-86. doi: 10.1002/ijc.21177. Int J Cancer. 2005. PMID: 15912532

7

Fine tuning the immune response through B7-H3 and B7-H4.

Yi KH, Chen L. Yi KH, et al. Immunol Rev. 2009 May;229(1):145-51. doi: 10.1111/j.1600-065X.2009.00768.x. Immunol Rev. 2009. PMID: 19426220 Free PMC article. Review.

8

Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction.

Nechushtan H, Pham D, Zhang Y, Morgensztern D, Yi KH, Shin SU, Federoff HJ, Bowers WJ, Tolba KA, Rosenblatt JD. Nechushtan H, et al. Among authors: yi kh. Cancer Immunol Immunother. 2008 May;57(5):663-75. doi: 10.1007/s00262-007-0405-1. Epub 2007 Oct 19. Cancer Immunol Immunother. 2008. PMID: 17952436 Free PMC article.

9

Potential role of chemokines in immune therapy of cancer.

Rosenblatt JD, Shin SU, Nechustan H, Yi KH, Tolba K. Rosenblatt JD, et al. Among authors: yi kh. Isr Med Assoc J. 2002 Nov;4(11):1054-9. Isr Med Assoc J. 2002. PMID: 12489506 Free article. Review. No abstract available.

10

Genu Varum Correction with HA Filler Volumisation of the Medial Gastrocnemius.

Hur JH, Wan J, Yoon SE, Spinato D, Viscomi B, Muniz M, Yi KH. Hur JH, et al. Among authors: yi kh. Aesthetic Plast Surg. 2024 Dec 23. doi: 10.1007/s00266-024-04598-7. Online ahead of print. Aesthetic Plast Surg. 2024. PMID: 39715867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters